Journal
CELLS
Volume 12, Issue 8, Pages -Publisher
MDPI
DOI: 10.3390/cells12081125
Keywords
5-ALA; 3D tumor models; neurological cancers; drug screening; glioblastoma; organoids; personalized medicine; spheroids; photodynamic therapy
Categories
Ask authors/readers for more resources
This study investigated the effects of 5-aminolevulinic acid (5-ALA)-mediated photodynamic therapy (PDT) on glioblastoma (GB) treatment and determined the optimal conditions for PDT efficacy without causing phototoxic injury to normal brain tissue. The results showed that 5-ALA/PDT effectively inhibited cancer cell proliferation and promoted apoptosis without significant effects on normal cells.
Background: The high recurrence of glioblastoma (GB) that occurs adjacent to the resection cavity within two years of diagnosis urges an improvement of therapies oriented to GB local control. Photodynamic therapy (PDT) has been proposed to cleanse infiltrating tumor cells from parenchyma to ameliorate short long-term progression-free survival. We examined 5-aminolevulinic acid (5-ALA)-mediated PDT effects as therapeutical treatment and determined optimal conditions for PDT efficacy without causing phototoxic injury to the normal brain tissue. Methods: We used a platform of Glioma Initiation Cells (GICs) infiltrating cerebral organoids with two different glioblastoma cells, GIC7 and PG88. We measured GICs-5-ALA uptake and PDT/5-ALA activity in dose-response curves and the efficacy of the treatment by measuring proliferative activity and apoptosis. Results: 5-ALA (50 and 100 mu g/mL) was applied, and the release of protoporphyrin IX (PpIX) fluorescence measures demonstrated that the emission of PpIX increases progressively until its stabilization at 24 h. Moreover, decreased proliferation and increased apoptosis corroborated the effect of 5-ALA/PDT on cancer cells without altering normal cells. Conclusions: We provide evidence about the effectiveness of PDT to treat high proliferative GB cells in a complex in vitro system, which combines normal and cancer cells and is a useful tool to standardize new strategic therapies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available